Key Takeaways
- Shenyi Technology secures funding to enhance R&D on brain-computer interface technologies and expand into consumer and medical markets.
- The company aims to integrate advanced neuromodulation techniques into daily life through wearable technology targeting brain health management.
- Collaboration with industry partners and investment from specialized funds will accelerate the development of innovative brain health solutions.
Funding for Innovation in Brain Health
Shenyi Technology, established in May 2025, is pioneering AI and brain science innovation. Its latest financing round is focused on developing core brain-computer interfaces (BCIs) and expanding its presence in both consumer and clinical markets. The funding will facilitate research and development of products aimed at managing conditions such as sleep disorders and depression, involving clinical verification and regulatory registration for medical-grade products.
The company has adopted a dual approach of “Serious Medical Care + Consumer Health.” This involves addressing clinical needs through EEG-based diagnostic tools and neuromodulation technologies while making wearable BCIs accessible for everyday use. By leveraging large-scale consumer product deployment, Shenyi Technology aims to create a feedback loop that fuels algorithm optimization and product refinement.
Advancements in Medical Applications
Shenyi Technology’s medical focus revolves around non-invasive neuromodulation. The company has introduced a closed-loop temporal interference (TI) stimulation device that offers precise, real-time adjustments based on EEG assessments. This equipment stands out as the first of its kind developed domestically for practical use, contrasting with traditional one-way stimulation techniques.
The firm is also exploring multi-modal acoustoelectric stimulation, combining ultrasound and electrical methods for enhanced precision and personalization in treatment. This development is part of a larger strategy to create a comprehensive neuromodulation platform addressing varying disease stages and patient needs.
Expanding Consumer Access to Brain Health Technology
On the consumer side, Shenyi Technology’s wearable BCIs utilize AI to monitor individuals’ brain states related to sleep and emotions, facilitating adaptive interventions. The goal is to make these technologies more compact and easier to use, thereby integrating seamlessly into daily life.
The company plans to develop a tiered product system to cater to both healthy individuals and patients with various degrees of brain disorders. This systematic approach aims to extend the functionalities of brain function monitoring and intervention from clinical settings to home environments.
Strategic Partnerships for Growth
The recent funding round led by Shenzhen Guangming Lihe Science City Seed Venture Capital Fund highlights significant investor confidence. With a focus on early-stage tech innovation, this partnership aims to harness Shenyi Technology’s capabilities in EEG acquisition, AI, and neuromodulation, enhancing the company’s industrialization goals.
In collaboration with institutions like the Shenzhen National Research Institute of High Performance Medical Devices, Shenyi Technology is positioned to drive the commercialization of cutting-edge brain health solutions. The firm’s commitment to integrating AI with BCIs aims to make these advanced technologies accessible to the general public, moving beyond mere laboratory applications.
As the team continues to build on its industry connections and R&D strengths, future efforts will focus on global market penetration and innovation in cognitive health technologies, targeting the mental health needs of millions worldwide.
The content above is a summary. For more details, see the source article.
